4//SEC Filing
STAPLETON CRAIG R 4
Accession 0001140361-18-032187
CIK 0001012477other
Filed
Jul 10, 8:00 PM ET
Accepted
Jul 11, 5:35 PM ET
Size
11.2 KB
Accession
0001140361-18-032187
Insider Transaction Report
Form 4
STAPLETON CRAIG R
Director
Transactions
- Award
ADSs
2018-07-09+57,315→ 350,328 total
Holdings
- 117,449
Warrants (right to buy)
Exercise: $13.59From: 2017-08-10Exp: 2020-08-10→ ADSs (117,449 underlying) - 210,400(indirect: By Spouse)
ADSs
- 117,449
Warrants (right to buy)
Exercise: $21.67From: 2016-06-26Exp: 2019-06-26→ ADSs (117,449 underlying) - 35,000
Stock Option (right to buy)
Exercise: $10.51From: 2018-06-28Exp: 2022-06-28→ ADSs (35,000 underlying)
Footnotes (6)
- [F1]The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
- [F2]Represents 57,315 restricted ADSs granted under the issuer's Omnibus Incentive Compensation Plan on 07/09/2018; one-third (1/3) of the ADSs will vest on each of the first three anniversaries of the grant date.
- [F3]The filing of this statement shall not be construed as an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of these securities.
- [F4]Warrants were granted 06/26/2015 but were not exercisable until the first anniversary of the date of grant; on such first anniversary the warrants became exercisable for a 3-year period as to all 117,449 ADSs. The warrant exercise price per ADS may be paid in U.S. Dollars as shown in Item 2 of Table II or in Euros based on the exchange rate prevailing on the date of grant, or (euro)19.34 per ADS.
- [F5]Warrants were granted 08/10/2016 but were not exercisable until the first anniversary of the date of grant; on such first anniversary the warrants became exercisable for a 3-year period as to all 117,449 ADSs. The warrant exercise price per ADS may be paid in U.S. Dollars as shown in Item 2 of Table II or in Euros based on the exchange rate prevailing on the date of grant, or (euro) 12.16 per ADS.
- [F6]Options became exercisable as to all 35,000 ADSs on the first anniversary of the 06/28/2017 grant date.
Documents
Issuer
AVADEL PHARMACEUTICALS PLC
CIK 0001012477
Entity typeother
Related Parties
1- filerCIK 0001207106
Filing Metadata
- Form type
- 4
- Filed
- Jul 10, 8:00 PM ET
- Accepted
- Jul 11, 5:35 PM ET
- Size
- 11.2 KB